Dulaglutide (Trulicity) Dulaglutide, marketed as Trulicity formulated as a fusion protein
Proc Natl Acad Sci USA 1996
As of early 2026, only 13 state Medicaid programs cover GLP-1 medications for weight loss, down from 17 states at the start of the year California, New Hampshire, Pennsylvania, and South Carolina dropped coverage on January 1, 2026, citing budgetary constraints from the high cost of medications like Ozempic, Wegovy, and Zepbound
Conclusion GLP-1A was conjugated with oligomeric DOCAs, and the resulting chimeric compound showed the potential not only for glucagon-like peptide-1 receptor agonist activity but also for oral delivery
Pediatric Use:Intake in children should be in the amount (0.5 to 3 mcg daily) recommended by the Food and Nutrition Board, National Academy of Science-National Research Council
How Do GLP-1 Medications Promote Weight Loss